InvestorsHub Logo
Followers 32
Posts 5818
Boards Moderated 0
Alias Born 05/23/2006

Re: westjtter post# 332890

Wednesday, 02/12/2020 2:56:12 PM

Wednesday, February 12, 2020 2:56:12 PM

Post# of 345969
I had a couple conversations with Mr. White as well.... this was all during the time SK was scrambling to save his butt and adding to the BOD to keep control. White did not hold back on his disdain for what SK was doing. So the Lias hire was basically to try to save SK and the old BOD.... if you can remember the old crew delayed the ASM and were desperately trying to sell the IP but we don't know the conditions of the sale ie whether the old BOD was attached to any IP deal... look at the IP now... three trials with Merck going on.... two with ketruda and one trial status was updated recently ...80 patients several sites.... so Avid hopefully is getting manuf rev..... another w/ 34 patients....

As for biz dev team, the Compton guy came from Cambrex which was recently sold to private equity in a $2.4 bil deal.... his resume was a lot stronger than TK imo... could this be a setup for another acquisition by private equity?

And hiring a CEO? they are teeing this up for sale imo so a CEO is not needed imo... Richie Rich is all they need to run the facility imo...

I check CDMO M&A activity every couple of days.... major consolidation is still going on and clients prefer fewer suppliers/vendors with more service offerings... and biomanuf operations are slim pickens...

I check CDMO capacity as well.... short term things are tight and expanding trials particularly w/ virus/vectors seem to outpace new capacity from what I gather... in some case companies are paying to reserve space...

Avid's BOD knows what is going on and two BOD members sold their CDMO's to major players... they know the drill...

Now if they don't start showing improvement soon, they could be a hostile takeover target imo...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News